American Regent debuts generic Cardene

American Regent is introducing nicardipine hydrochloride injection.

The product, which is a generic of EKR Therapeutics’ Cardene, is a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible.

"American Regent is pleased to be bringing back this shortage-prone product in a USP formulation, and to offer health care providers another option for the treatment of hypertension," said Harsher Singh, American Regent vice president, chief commercial and strategic officer.

The product is available for immediate shipment.